[go: up one dir, main page]

CL2011000296A1 - Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. - Google Patents

Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.

Info

Publication number
CL2011000296A1
CL2011000296A1 CL2011000296A CL2011000296A CL2011000296A1 CL 2011000296 A1 CL2011000296 A1 CL 2011000296A1 CL 2011000296 A CL2011000296 A CL 2011000296A CL 2011000296 A CL2011000296 A CL 2011000296A CL 2011000296 A1 CL2011000296 A1 CL 2011000296A1
Authority
CL
Chile
Prior art keywords
octahydro
indole
oxo
carboxylic acid
methyl ester
Prior art date
Application number
CL2011000296A
Other languages
English (en)
Inventor
Gottfried Sedelmeier
Murat Acemoglu
Philipp Lustenberger
Ernst Kuesters
Beast Schmidt
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41278189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000296(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2011000296A1 publication Critical patent/CL2011000296A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Proceso para la producción de un compuesto derivado de éster metílico del ácido 4-oxo-octahidro-indol-1-carboxílico; compuestos intermediarios y procesos para prepararlos.
CL2011000296A 2008-08-12 2011-02-11 Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. CL2011000296A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8815608P 2008-08-12 2008-08-12

Publications (1)

Publication Number Publication Date
CL2011000296A1 true CL2011000296A1 (es) 2011-11-04

Family

ID=41278189

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000296A CL2011000296A1 (es) 2008-08-12 2011-02-11 Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.

Country Status (21)

Country Link
US (1) US8084487B2 (es)
EP (1) EP2315748B1 (es)
JP (1) JP5468608B2 (es)
KR (1) KR101673634B1 (es)
CN (1) CN102119151A (es)
AU (1) AU2009281218B2 (es)
BR (1) BRPI0917492A8 (es)
CA (1) CA2732095C (es)
CL (1) CL2011000296A1 (es)
CO (1) CO6341608A2 (es)
EC (1) ECSP11010883A (es)
ES (1) ES2547269T3 (es)
IL (1) IL210835A (es)
MA (1) MA32618B1 (es)
MX (1) MX2011001664A (es)
MY (1) MY151183A (es)
NZ (1) NZ590753A (es)
PE (1) PE20110415A1 (es)
RU (1) RU2513856C2 (es)
WO (1) WO2010018154A1 (es)
ZA (1) ZA201100558B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012084873A1 (en) 2010-12-20 2012-06-28 Novartis Ag 4- (hetero) aryl - ethynyl - octahydro - indole - 1 - carboxylic acid esters
US9067881B2 (en) 2011-01-24 2015-06-30 Novartis Ag 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives
EP2650284A1 (en) 2012-04-10 2013-10-16 Merz Pharma GmbH & Co. KGaA Heterocyclic derivatives as metabotropic glutamate receptor modulators
GB201312800D0 (en) 2013-07-17 2013-08-28 Heptares Therapeutics Ltd mGlu5 modulators
KR20200035035A (ko) 2017-07-31 2020-04-01 노파르티스 아게 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도
CN119837862A (zh) 2017-07-31 2025-04-18 诺华股份有限公司 玛沃谷兰在减少酒精使用或在预防复用酒精中的用途
CN113301894A (zh) * 2019-01-29 2021-08-24 诺华股份有限公司 mGluR5拮抗剂用于治疗阿片类物质镇痛耐受性的用途
EP4181918A2 (en) * 2020-07-17 2023-05-24 Novartis AG Mavoglurant, a mglur5 antagonist, for use in the treatment in the reduction of opioid use
WO2022123482A1 (en) 2020-12-11 2022-06-16 Novartis Ag Use of mglur5 antagonists for treating amphetamine addiction
CA3204360A1 (en) 2020-12-14 2022-06-23 Novartis Ag Use of mglur5 antagonists for treating gambling disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128996D0 (en) * 2001-12-04 2002-01-23 Novartis Ag Organic compounds
GB0514296D0 (en) * 2005-07-12 2005-08-17 Novartis Ag Organic compounds
CA2663113A1 (en) * 2006-09-11 2008-03-20 Novartis Ag Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
JP5743545B2 (ja) * 2007-10-12 2015-07-01 ノバルティス アーゲー パーキンソン病処置用代謝型グルタミン酸受容体モジュレーター
BRPI0913642A2 (pt) * 2008-06-30 2015-11-24 Novartis Ag produtos de combinação

Also Published As

Publication number Publication date
JP2011530566A (ja) 2011-12-22
BRPI0917492A8 (pt) 2016-07-05
CN102119151A (zh) 2011-07-06
MX2011001664A (es) 2011-03-25
MY151183A (en) 2014-04-30
KR101673634B1 (ko) 2016-11-07
WO2010018154A1 (en) 2010-02-18
ZA201100558B (en) 2011-10-26
RU2011108663A (ru) 2012-09-20
ECSP11010883A (es) 2011-04-29
BRPI0917492A2 (pt) 2015-08-04
RU2513856C2 (ru) 2014-04-20
PE20110415A1 (es) 2011-07-04
CA2732095C (en) 2017-04-25
HK1155733A1 (en) 2012-05-25
JP5468608B2 (ja) 2014-04-09
ES2547269T3 (es) 2015-10-05
CO6341608A2 (es) 2011-11-21
EP2315748A1 (en) 2011-05-04
KR20110042222A (ko) 2011-04-25
EP2315748B1 (en) 2015-06-24
IL210835A0 (en) 2011-04-28
NZ590753A (en) 2012-06-29
US20110144352A1 (en) 2011-06-16
MA32618B1 (fr) 2011-09-01
AU2009281218B2 (en) 2013-05-16
CA2732095A1 (en) 2010-02-18
AU2009281218A1 (en) 2010-02-18
US8084487B2 (en) 2011-12-27
IL210835A (en) 2016-05-31

Similar Documents

Publication Publication Date Title
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
CY1125155T1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
CU24354B1 (es) Procedimiento de obtención de derivados de tetrafluoropropilmorfolina
GT201300078A (es) Proceso para la preparacion de inhibidores de pan-cdk de la formula ( i ), e intermediarios de la preparacion
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
BR112014018756A8 (pt) Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
MY150280A (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
IN2014DN00144A (es)
SG195111A1 (en) Process for preparing methacrylic acid
CU20090009A7 (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
EP2471942A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
PT2462098E (pt) Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico
CO6430457A2 (es) Proceso para la preparación de amidas del ácido pirazol carboxilico
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
CL2012003371A1 (es) Compuestos intermediarios de la síntesis de agomelatina; y el procedimiento de obtención de agomelatina a partir de dichos compuestos intermediarios
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
WO2014087208A3 (en) A process of preparing alcaftadine
CR20120630A (es) Nuevos procesos
MX337997B (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX2020009462A (es) Procesos para la preparación de compuestos de pirimidinilciclopentano.
CL2012001081A1 (es) Procesos de preparcion de compuestos intermediarios en la sintesis de valsartan por hidrolisis de un ester utilizando salesde aluminio.
MX2013008361A (es) Procedimiento para la preparacion de derivados 1-h-pirrolidin-2,4-diona.